Abnormal cerebral phospholipid metabolism in dyslexia indicated by phosphorus-31 magnetic resonance spectroscopy

NMR in Biomedicine

Volumn 10, Issue 7, 1997, Pages 309-314

  Richardson, Alexandra J ^a,b   Cox, I Jane ^c   Sargentoni, Janet ^c   Puri, Basant K ^c  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

Dyslexia; MRS; Phospholipid metabolism; Phospholipids; Phosphomonoester

Indexed keywords

PHOSPHOETHANOLAMINE; PHOSPHOLIPID; PHOSPHORYLCHOLINE;

ADULT; ARTICLE; BRAIN METABOLISM; CLINICAL ARTICLE; DYSLEXIA; FEMALE; HUMAN; MALE; METABOLIC DISORDER; PHOSPHOLIPID METABOLISM; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL;

ADULT; ANALYSIS OF VARIANCE; CEREBRAL CORTEX; DYSLEXIA; FEMALE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; METABOLISM, INBORN ERRORS; PHOSPHOLIPIDS; PHOSPHORUS ISOTOPES;

EID: 0031473218     PISSN: 09523480     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1492(199710)10:7<309::AID-NBM484>3.0.CO;2-0     Document Type: Article

References (30)

1. DeFries, J. C., Fulker, D. W. and La Buda, M. C. Evidence for a genetic aetiology in reading disability of twins. Nature 329, 537-539 (1987).
2. Miles, T. R. Dyslexia: The Pattern of Difficulties. Blackwell, Oxford (1994).
3. Nicolson, R. I. and Fawcett, A. J. Comparison of deficits in cognitive and motor skills among children with dyslexia. Ann. Dyslexia 44, 147-164 (1992).
4. Hooper, S. and Willis, W. G. Learning Disability Subtyping: Neuropsychological Foundations, Conceptual Models and Issues in Clinical Differentiation. Springer, New York (1989).
5. Stanovich, K. E., Siegel, L. S. and Gottardo, A. Progress in the search for dyslexia subtypes. In Dyslexia: Biology, Cognition and Intervention, C. Hulme and M. Snowling (eds). British Dyslexia Association, Whurr, London (1997).
6. Galaburda, A. M., Sherman, G. F., Rosen, G. D., Aboitiz, F. and Geschwind, N. Developmental dyslexia: Four consecutive patients with cortical anomalies. Ann. Neurol. 18, 222-233 (1985).
7. Horrobin, D. F., Glen, A. I. M. and Hudson, C. J. Possible relevance of phospholipid abnormalities and genetic interactions in psychiatric disorders: the relationship between dyslexia and schizophrenia. Med. Hypotheses 45, 605-613 (1995).
8. Nunez, E. A. (ed.) Fatty acids and cell signalling. Prostaglandins Leukot. Essent. Fatty Acids 48, 1-22 (1993).
9. Crawford, M. A. Essential fatty acids and neurodevelopmental disorder. In Neurobiology of Essential Fatty Acids, N. G. Bazan (ed.). Plenum Press, New York (1992).
10. Horrobin, D. F., Glen, A. I. M. and Vaddadi, K. The membrane hypothesis of schizophrenia. Schizophr. Res. 13, 195-207 (1994).
11. Richardson, A. J. Dyslexia, handedness and syndromes of psychosis-proneness. Int. J. Psychophysiol. 13, 251-263 (1994).
12. Richardson, A. J. Dyslexia and schizotypy. In Schizotypy: Relations with Illness and Health, G. S. Claridge (ed.), pp. 171-201. Oxford University Press: Oxford (1997).
13. Dykman, R. A. and Ackerman, P. T. Attention deficit disorder and specific reading disability: Separate but often overlapping disorders. J. Learn. Disabil. 24, 96-103 (1991).
14. Stevens, L. J., Zentall, S. S., Deck, J. L., Abate, M. L., Watkins, B. A., Lipp, S. R. and Burgess, J. R. Essential fatty acid metabolism in boys with attention-deficit hyperactivity disorder. Am. J. Clin. Nutr. 62, 761-768 (1995).
15. Stordy, B. J. Benefit of docosahexaenoic acid supplements to dark adaptation in dyslexia. Lancet 346, 385 (1995).
16. Pettegrew, J. W., Keshavan, M. S., Panchalingam, K., Strychor, S., Kaplan, G. B., Tretta, M. G. and Allen, M. Alterations in brain high-energy phosphate and membrane phospholipid metabolism in first-episode, drug-naive schizophrenics. A pilot sudy of the dorsal prefrontal cortex by in vivo phosphorus 31 nuclear magnetic resonance. Arch. Gen. Psychiatry 48, 563-68 (1991).
17. 31P MR spectroscopy study. Schizophr. Res. 13, 209-215 (1994).
18. Coutts, G. A., Cox, I. J., Gadian, D. G., Sargentoni, J., Bryant, D. J. and Collins, A. G. Phosphorus-31 magnetic resonance spectroscopy of the normal human brain: approaches using four-dimensional chemical shift imaging and phase mapping techniques. NMR Biomed. 1, 190-197 (1989).
19. Saeed, N. and Menon, D. K. A knowledge-based approach to minimise baseline roll in chemical shift imaging. Magn. Reson. Med. 29, 591-598 (1993).
20. Taylor-Robinson, S. D., Beli, J. D., Sargentoni, J., Bryant, D. J., Mallalieu, R. J. and Morgan, M. Y. Cerebral phosphorus-31 magnetic resonance spectroscopy in patients with chronic hepatic encephalopathy. Hepatology 20, 1173-1178 (1994).
21. 31P magnetic resonance. J. Biol. Chem. 248, 7276-7278 (1973).
22. SPSS inc. SPSS for Windows. Chicago: SPSS Inc., 1993.
23. Dawson, R. M. C. Enzymatic pathways of phospholipid metabolism in the nervous system. In Phospholipids in Nervous Tissues, J. Eichber (ed.), pp. 45-78. Wiley, New York (1985).
24. 31P Nuclear magnetic resonance studies of phosphoglyceride metabolism in developing and degenerating brain: Preliminary observations. J. Neuropathol. Exp. Neurol. 46, 419-430 (1987).
25. Negendank, W. Studies of human tumors by MRS: A review. NMR Biomed. 5, 303-324 (1992).
26. Ruiz-Cabello, J. and Cohen, J. S. Phospholipid metabolites as indicators of cancer cell function. NMR Biomed. 5, 226-233.
27. 31P MRS. J. Affect. Disord. 22, 185-190 (1991).
28. Stanley, J. A., Wiliamson, P. C., Drost, D. J., Carr, T. J., Rylett, J., Malla, A. and Thompson, R. T. An in vivo study of the prefrontal cortex of schizophrenic patients at different stages of illness via phosphorus magnetic resonance spectroscopy. Arch. Gen. Psychiatry 52, 399-406 (1995).
29. Neuringer, M., Reisbeck S. and Janowsky, J. The role of n-3 fatty acids in visual and cognitive development. J. Pediatr. 125, 539-547 (1994).
30. Makrides, M., Newmann, M., Simmer, K., Pater, J. and Gibson, R. Are long-chain polyunsaturated fatty acids essential nutrients in infancy? Lancet 345, 1463-1468 (1995).